Novartis AG Sponsored ADR
American Depositary Receipt · NYSE
Live TMS charts are coming soon.
Paper trading. Simulated, no real money.
No public theses on NVS yet. When TMS traders open paper trades on it and make their thesis public, the long and short split, average conviction and hit rate show here.
Key stats load once market data is connected.
Novartis management held a meeting covering its growth outlook, cash flow and R&D pipeline, and a transcript of the discussion was published. The headline alone gives no details of specific figures or decisions.
Novartis shares fell after the company updated its mid-term outlook. The headline gives no detail on the revised targets, and Ionis Pharmaceuticals is also named by the feed.
Novartis management presented on its growth outlook, cash flow and R&D pipeline at a meeting, according to a slideshow. The headline alone gives no figures or new announcements.
No SEC financials for NVS yet. Companies that file 10-K and 10-Q reports show revenue, earnings, cash flow and the balance sheet here.
Source: SEC filings (10-K, 10-Q).
Paper trading only. Nothing here is financial advice.